AMAG Pharmaceuticals, Inc. (AMAG): Price and Financial Metrics

AMAG Pharmaceuticals, Inc. (AMAG): $13.75

0.02 (+0.15%)

POWR Rating

Component Grades








Add AMAG to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




in industry

AMAG Price/Volume Stats

Current price $13.75 52-week high $13.80
Prev. close $13.73 52-week low $4.41
Day low $13.75 Volume 1,534,500
Day high $13.76 Avg. volume 950,664
50-day MA $12.08 Dividend yield N/A
200-day MA $9.17 Market Cap 477.47M

AMAG Stock Price Chart Interactive Chart >

AMAG Pharmaceuticals, Inc. (AMAG) Company Bio

AMAG Pharmaceuticals has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. The company was founded in 1981 and is based in Waltham, Massachusetts.

AMAG Latest News Stream

Event/Time News Detail
Loading, please wait...

AMAG Latest Social Stream

Loading social stream, please wait...

View Full AMAG Social Stream

Latest AMAG News From Around the Web

Below are the latest news stories about Amag Pharmaceuticals Inc that investors may wish to consider to help them evaluate AMAG as an investment opportunity.

Covis takes out Amag Pharma for $498M

Apollo Global Management portfolio company Covis Group S.à r.l. has agreed to acquire AMAG Pharmaceuticals ([[AMAG]] +43.9%) for $13.75 per share in cash. The total transaction value is ~$498M on a fully diluted basis or ~$647M on an enterprise basis including debt.The tender offer for AMAG shares will commence this...

Seeking Alpha | October 1, 2020

AMAG Pharma up 41% on takeover rumor

AMAG Pharmaceuticals (AMAG) jumps 41% after hours in apparent response to rumors that Apollo Global (APO) portfolio company Covis Pharma is about to acquire the company.Covis is a Netherlands-based specialty pharmaceutical company that only months ago was purchased by Apollo for an undisclosed sum.It's been a rough few years for AMAG, which...

Seeking Alpha | September 30, 2020

AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

AMAG Pharmaceuticals (AMAG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand

Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties   Collaboration further advances the development of ciraparantagWALTHAM, Mass. and AMSTERDAM, The Netherlands, July 23, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Norgine B.V., a leading European specialist pharmaceutical company, today announced they have entered into an exclusive licensing agreement to develop and commercialize ciraparantag in Europe, Australia and New Zealand. Ciraparantag is in development for use in patients treated with direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) when reversal of the anticoagulant effect of these products is needed f...

Yahoo | July 23, 2020

When Will AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Breakeven?

AMAG Pharmaceuticals, Inc.'s (NASDAQ:AMAG): AMAG Pharmaceuticals, Inc., a pharmaceutical company, develops...

Yahoo | July 21, 2020

Read More 'AMAG' Stories Here

AMAG Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year 16.43%
2023 N/A
2022 N/A
2021 N/A
2020 0.00%
2019 -19.88%

Continue Researching AMAG

Want to see what other sources are saying about Amag Pharmaceuticals Inc's financials and stock price? Try the links below:

Amag Pharmaceuticals Inc (AMAG) Stock Price | Nasdaq
Amag Pharmaceuticals Inc (AMAG) Stock Quote, History and News - Yahoo Finance
Amag Pharmaceuticals Inc (AMAG) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!